$33m raised for a p2 cancer stem cell co it appears, go figurehttp://www.fiercebiotech.com/story/first-biotech-ipo-13-jumps-encouraging-debut/2013-01-30
PTX This rare type of lymphoma ruins the body – so do existing treatments. Prescient could have a solution